Q4 Review: Biocon's Kiran Mazumdar Shaw On Earnings & FY23 Projections
  • 2 years ago
#Q4WithBQ | Biocon's Q4 net profit surpasses estimate but margins see a contraction on a yearly basis.
Executive Chairperson Kiran Mazumdar Shaw shares growth projections for FY23 along with strategies to boost growth. #BQLive
Recommended